Profile data is unavailable for this security.
About the company
Mannatech, Incorporated is a global wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, Essentials, and Home Living. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies. Home Living includes Organt and PURO.
- Revenue in USD (TTM)131.96m
- Net income in USD-2.24m
- Incorporated1993
- Employees213.00
- LocationMannatech Inc1410 Lakeside Parkway, Suite 200FLOWER MOUND 75028United StatesUSA
- Phone+1 (972) 471-7400
- Fax+1 (972) 471-8135
- Websitehttps://us.mannatech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neurobo Pharmaceuticals Inc | 0.00 | -12.47m | 15.01m | 8.00 | -- | 0.8998 | -- | -- | -2.71 | -2.71 | 0.00 | 3.40 | 0.00 | -- | -- | 0.00 | -44.29 | -95.57 | -64.66 | -135.64 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 10.72 | -- | 75.54 | -- |
| Cocrystal Pharma Inc | 0.00 | -17.98m | 15.36m | 12.00 | -- | 0.5823 | -- | -- | -1.90 | -1.90 | 0.00 | 2.59 | 0.00 | -- | -- | 0.00 | -49.89 | -50.94 | -53.19 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
| Vaxxinity Inc | 0.00 | -56.94m | 15.39m | 57.00 | -- | 1.15 | -- | -- | -0.4499 | -0.4499 | 0.00 | 0.1058 | 0.00 | -- | -- | 0.00 | -75.56 | -- | -111.46 | -- | -- | -- | -- | -- | -- | -- | 0.5308 | -- | -- | -- | 24.31 | -- | -- | -- |
| Avalo Therapeutics Inc | 1.93m | -31.54m | 15.49m | 19.00 | -- | 1.64 | -- | 8.05 | -381.36 | -381.36 | 6.94 | 9.11 | 0.0708 | 128.50 | 1.87 | 101,315.80 | -116.06 | -99.64 | -228.35 | -154.42 | 33.25 | 84.69 | -1,638.65 | -613.58 | 1.82 | -5.67 | 0.00 | -- | -89.34 | -22.83 | 24.28 | -- | -22.48 | -- |
| Cardio Diagnostics Holdings Inc | 17.07k | -8.38m | 15.60m | 7.00 | -- | 5.02 | -- | 913.73 | -0.7363 | -0.7363 | 0.0014 | 0.144 | 0.0032 | -- | 6.88 | 2,438.57 | -156.40 | -- | -211.46 | -- | -- | -- | -49,073.46 | -- | -- | -5.45 | 0.1122 | -- | 1,696.84 | -- | -79.72 | -- | -- | -- |
| Mannatech Inc | 131.96m | -2.24m | 15.72m | 213.00 | -- | 1.48 | -- | 0.1191 | -1.21 | -1.21 | 70.53 | 5.64 | 2.92 | 1.99 | 854.08 | 619,507.10 | -4.96 | 4.39 | -12.90 | 9.16 | 77.95 | 77.87 | -1.70 | 1.72 | 0.5093 | -5.81 | 0.1226 | 88.33 | -3.83 | -5.33 | 50.13 | -- | -20.38 | -- |
| Aytu Biopharma Inc | 98.50m | -18.00m | 15.81m | 150.00 | -- | 0.4813 | -- | 0.1605 | -4.06 | -4.06 | 20.97 | 5.90 | 0.7224 | 2.79 | 3.59 | 656,653.30 | -13.20 | -33.56 | -25.46 | -52.81 | 63.24 | 56.89 | -18.27 | -73.81 | 0.9094 | -0.4382 | 0.3281 | -- | 11.10 | 96.56 | 84.33 | -- | -- | -- |
| Protext Mobility Inc | 750.00 | -2.21m | 15.82m | 4.00 | -- | -- | -- | 21,098.93 | -0.4692 | -0.4692 | 0.00001 | -0.0102 | 0.0405 | -- | -- | -- | -9,400.97 | -1,587.94 | -- | -- | 86.67 | -530.19 | -232,392.00 | -17,498.83 | 0.0002 | -1.36 | -- | -- | -93.98 | -63.09 | 27.35 | -- | -- | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 15.85m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Traws Pharma Inc | 226.00k | -18.95m | 16.00m | 16.00 | -- | 1.24 | -- | 70.81 | -0.9029 | -0.9029 | 0.0108 | 0.5081 | 0.0073 | -- | 9.62 | 14,125.00 | -61.07 | -63.43 | -84.61 | -85.72 | -- | -- | -8,384.07 | -3,257.92 | -- | -- | 0.00 | -- | 0.00 | -28.72 | 0.0844 | -- | -- | -- |
| Dominari Holdings Inc | 2.04m | -22.88m | 16.02m | 26.00 | -- | 0.3028 | -- | 7.86 | -4.44 | -4.44 | 0.3899 | 8.92 | 0.0305 | -- | 0.3829 | 78,423.08 | -34.20 | -26.82 | -35.10 | -27.45 | -- | -- | -1,122.22 | -3,353.52 | -- | -- | 0.00 | -- | -- | 135.75 | 12.72 | -- | 63.99 | -- |
| Mystic Holdings Inc | -100.00bn | -100.00bn | 16.22m | 79.00 | -- | 0.6496 | -- | -- | -- | -- | -- | 0.2155 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.2228 | -- | 0.1849 | -- | 199.82 | -- | 34.32 | -- | -- | -- |
| Oncotelic Therapeutics Inc | 70.00k | -7.90m | 16.31m | 22.00 | -- | 1.34 | -- | 232.96 | -0.02 | -0.02 | 0.0002 | 0.0304 | 0.0021 | -- | 3.61 | 3,181.82 | -24.82 | -25.03 | -49.08 | -48.76 | -- | -- | -11,722.94 | -1,692.93 | -- | -0.4788 | 0.5199 | -- | -- | -- | -255.12 | -- | -- | -- |
| Talis Biomedical Corp | 2.13m | -62.01m | 16.40m | 99.00 | -- | 0.2373 | -- | 7.68 | -34.26 | -34.26 | 1.18 | 37.93 | 0.0162 | -- | 11.92 | 21,555.55 | -46.98 | -68.18 | -51.14 | -74.22 | 98.08 | -- | -2,905.67 | -1,615.96 | -- | -- | 0.00 | -- | -55.65 | -2.24 | 45.13 | -- | -1.83 | -- |
| Allied Corp | 21.51k | -9.00m | 16.42m | -- | -- | -- | -- | 763.50 | -0.0915 | -0.0915 | 0.0002 | -0.0711 | 0.0051 | 1.65 | 0.1441 | -- | -214.39 | -- | -- | -- | -6,919.57 | -- | -41,861.41 | -- | 0.0333 | -31.86 | -- | -- | -56.46 | -- | 31.30 | -- | -- | -- |
| Solarwindow Technologies Inc | 0.00 | -2.36m | 16.49m | 1.00 | -- | 2.55 | -- | -- | -0.0443 | -0.0468 | 0.00 | 0.1214 | 0.00 | -- | -- | 0.00 | -25.51 | -44.62 | -26.29 | -45.23 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 44.04 | -- | -- | -- |
Data as of Apr 26 2024. Currency figures normalised to Mannatech Inc's reporting currency: US Dollar USD
20.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Sudbury Capital Management LLCas of 20 Apr 2023 | 138.25k | 7.43% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 52.40k | 2.82% |
| Bridgeway Capital Management LLCas of 31 Dec 2023 | 46.12k | 2.48% |
| Acadian Asset Management LLCas of 31 Dec 2023 | 39.50k | 2.12% |
| The Vanguard Group, Inc.as of 31 Dec 2023 | 38.51k | 2.07% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 35.80k | 1.93% |
| IFG Advisory LLCas of 31 Dec 2023 | 19.09k | 1.03% |
| LSV Asset Managementas of 31 Dec 2023 | 7.87k | 0.42% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 2.45k | 0.13% |
| Tower Research Capital LLCas of 31 Dec 2023 | 865.00 | 0.05% |
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
